Biotechnologies to watch

被引:10
作者
Persidis, A
机构
[1] Aris Persidis is vice president for business development atArgonex Inc.,
关键词
D O I
10.1038/nbt1297-1409
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Which technologies promise to make significant contributions to biotechnology's drug pipeline?
引用
收藏
页码:1409 / 1411
页数:3
相关论文
共 8 条
[1]   Ribozyme therapeutics [J].
Persidis, A .
NATURE BIOTECHNOLOGY, 1997, 15 (09) :921-922
[2]   Catalytic antibodies [J].
Persidis, A .
NATURE BIOTECHNOLOGY, 1997, 15 (12) :1313-+
[3]  
Persidis A, 1997, NAT BIOTECHNOL, V15, P479, DOI 10.1038/nbt0597-479
[4]   Artificial intelligence for drug design [J].
Persidis, A ;
Persidis, A .
NATURE BIOTECHNOLOGY, 1997, 15 (10) :1035-1036
[5]   Critical issues in gene therapy commercialization [J].
Persidis, A ;
Tomczyk, MS .
NATURE BIOTECHNOLOGY, 1997, 15 (07) :689-690
[6]   Combinatorial chemistry [J].
Persidis, A .
NATURE BIOTECHNOLOGY, 1997, 15 (04) :391-392
[7]  
*PHRMA, 1996, BIOT MED DEV
[8]  
TAUREL S, 1997, PHARM STRAT ALL C NE